Do all gliflozins reduce stroke in patients with type 2 diabetes mellitus and impaired renal function?

Zhao, Li-Min; Ding, Liang-Liang; Zhan, Ze-Lin; Qiu, Mei

Zhao, Li-Min; Ding, Liang-Liang; Zhan, Ze-Lin; Qiu, Mei.

Afiliación

Zhao LM; Department of Endocrinology, Shenzhen Longhua District Central Hospital, Shenzhen 518110, China. Electronic address: limin_zhao223@sina.com.
Ding LL; Department of Endocrinology, First Affiliated Hospital of Yangtze University, Jingzhou 434000, China. Electronic address: 15887847798m0@sina.cn.
Zhan ZL; Clinical medicine, Grade 2019, The Second Clinical Medical College, Southern Medical University, China. Electronic address: zhan_zelin2021@sina.com.
Qiu M; Department of General Medicine, Shenzhen Longhua District Central Hospital, Shenzhen 518110, China. Electronic address: 13798214835@sina.cn.

J Stroke Cerebrovasc Dis ; 30(7): 105799, 2021 07.

Article en En | MEDLINE | ID: mdl-33879370

Asunto(s)

Diabetes Mellitus Tipo 2; Inhibidores del Cotransportador de Sodio-Glucosa 2; Accidente Cerebrovascular; Humanos; Hipoglucemiantes; Riñón/fisiología

Palabras clave

Chronic kidney disease; Gliflozins; SGLT2 inhibitors; Stroke; Type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Accidente Cerebrovascular / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 Límite: Humans Idioma: En Revista: J Stroke Cerebrovasc Dis Asunto de la revista: ANGIOLOGIA / CEREBRO Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google